Search
for
Sort by
Research 301–330 of 1000+
- Mucocutaneous reactions to chemotherapy
- Severe cutaneous adverse reactions to drugs
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Topical use of systemic drugs in dermatology: A comprehensive review
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Effect of Tectona grandis Linn. seeds on hair growth activity of albino mice
- Dermatologic Problems of Older Women
- Common Dermatologic Conditions
- Physiological Doses of Red Light Induce IL‐4 Release in Cocultures between Human Keratinocytes and Immune Cells
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Frontal fibrosing alopecia in Asians: a retrospective clinical study
- Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review
- Endoscopic Browplasty
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Crowdsourcing Dermatology Images with Google Search Ads: Creating a Real-World Skin Condition Dataset
- A CLINICAL STUDY OF GERIATRIC DERMATOSES
- Alternative Medicine for Hair Loss
- Psychosocial Aspects of Skin Conditions and Diseases
- Poster Abstracts
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Dermatological adverse events with taxane chemotherapy
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat
- Scalp Itch: A Systematic Review
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma